1e
19
1
49
2
2
18
1b
1d
18
2e
5e
1d
2 29
1d
25
Malki Peskin, MD
88
5e
Assistant Professor of Clinical Pediatrics (Rheumatology)
28
89
3
61
Attending Physician, Division of Rheumatology, Children's Hospital of Philadelphia
11
Department: Pediatrics
4
1
b
1d
46
Contact information
51
4
3
3
3
2
4
b
1f
51
Children's Hospital of Philadelphia
20 Division of Rheumatology
3a 3401 Civic Center Blvd.
Philadelphia, PA 19104
26
20 Division of Rheumatology
3a 3401 Civic Center Blvd.
Philadelphia, PA 19104
30
Office: (516) 680-3200
30
81
30
Email:
peskinm@chop.edu
12
peskinm@chop.edu
13
Education:
21 7 BA 14 (Biology) c
2b Yeshiva University, 2012.
21 7 MD 15 (Medicine) c
3c Albert Einstein College of Medicine, 2017.
c
3
3
3
3
8d
Permanent link21 7 BA 14 (Biology) c
2b Yeshiva University, 2012.
21 7 MD 15 (Medicine) c
3c Albert Einstein College of Medicine, 2017.
c
2 29
21
1e
1d
24
2b
29
27
23
182 Rothschild EF, Peskin M, Perfetto J, Akinsete A, Ramos M, Wahezi DM, Cabana MD.: Evaluation of Factors Influencing Successful Completion of a Pediatric Rheumatology Evaluation after Primary Referral. American Academy of Pediatrics National Convention and Exhibition, Anaheim, CA, poster presentation October 2022.
107 Lanis, A, Peskin, M, Akinsete, A, Tarshish, G, Tu, E, Rubinstein, T.: Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study. Healthcare 10(10): 1979, October 2022.
12a Mostowy M, Peskin M, Velez J, Perron MM, Wahezi D.: The use of rituximab in children with juvenile dermatomyositis and anti-MDA5 antibodies Global Conference on Myositis, Prague, Czech Republic, poster presentation May 2022.
e2 Akinsete A, Peskin M, Perfetto J: A Possible Diagnostic Tool: RheumMadness 2022 AI: JIA Subtypes Scouting Report. The Rheumatologist 16(5): 93, May 2022.
171 Peskin M, Fiori K, Ramos M, Hoffman A, Wahezi D, Rubinstein T, Goilav B.: Medication Adherence in Patients with Childhood-onset Systemic Lupus Erythematosus (cSLE): A Quality Improvement Study. Children’s Hospital at Montefiore Pediatric Research Day, Bronx, NY, poster presentation April 2022.
10c Leverenz D, Peskin M, Carter S, Fuchs P, Garren A, Criscione-Schreiber L: Machines Region. RheumMaddness Podcast March 2022 Notes: Interviewed by Dr. David Leverenz (Assistant Professor at Duke).
6b Lanis A, Peskin M, Akinsete A, Tarshish G, Tu E, Rubinstein T. d5 : Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study. American College of Rheumatology Annual Meeting, San Diego, CA, poster presentation November 2021.
91 Wahezi, D, Peskin, M, Tanner, T: The Impact of the COVID-19 Pandemic on the Field of Pediatric 60 Rheumatology. Current Opinion in Rheumatology 33(5): 446-452, June 2021.
13e Peskin, M, Rubinstein, T, Jordan, N, Putterman, C, Wahezi, D: Evaluation of Mild to Moderate SLE Flare in Patient with Childhood-Onset Disease. American College of Rheumatology Annual Meeting, Washington, D.C., poster presentation November 2016.
2c
7
1d
1f
Selected Publications
190 Peskin, M, Mostowy, M, Velez, J, Perron, M, Kurian, J, Wahezi, DM: Clinical Improvement in Early Onset Interstitial Lung Disease Using Rituximab in Children With Antimelanoma Differentiation-Associated Gene 5-Positive Juvenile Dermatomyositis. The Journal of Rheumatology 51(4): doi: 10.3899, September 2024 Notes: ecollection.182 Rothschild EF, Peskin M, Perfetto J, Akinsete A, Ramos M, Wahezi DM, Cabana MD.: Evaluation of Factors Influencing Successful Completion of a Pediatric Rheumatology Evaluation after Primary Referral. American Academy of Pediatrics National Convention and Exhibition, Anaheim, CA, poster presentation October 2022.
107 Lanis, A, Peskin, M, Akinsete, A, Tarshish, G, Tu, E, Rubinstein, T.: Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study. Healthcare 10(10): 1979, October 2022.
12a Mostowy M, Peskin M, Velez J, Perron MM, Wahezi D.: The use of rituximab in children with juvenile dermatomyositis and anti-MDA5 antibodies Global Conference on Myositis, Prague, Czech Republic, poster presentation May 2022.
e2 Akinsete A, Peskin M, Perfetto J: A Possible Diagnostic Tool: RheumMadness 2022 AI: JIA Subtypes Scouting Report. The Rheumatologist 16(5): 93, May 2022.
171 Peskin M, Fiori K, Ramos M, Hoffman A, Wahezi D, Rubinstein T, Goilav B.: Medication Adherence in Patients with Childhood-onset Systemic Lupus Erythematosus (cSLE): A Quality Improvement Study. Children’s Hospital at Montefiore Pediatric Research Day, Bronx, NY, poster presentation April 2022.
10c Leverenz D, Peskin M, Carter S, Fuchs P, Garren A, Criscione-Schreiber L: Machines Region. RheumMaddness Podcast March 2022 Notes: Interviewed by Dr. David Leverenz (Assistant Professor at Duke).
6b Lanis A, Peskin M, Akinsete A, Tarshish G, Tu E, Rubinstein T. d5 : Storytelling of Young Adults with Chronic Rheumatologic Illnesses: A Pilot Study. American College of Rheumatology Annual Meeting, San Diego, CA, poster presentation November 2021.
91 Wahezi, D, Peskin, M, Tanner, T: The Impact of the COVID-19 Pandemic on the Field of Pediatric 60 Rheumatology. Current Opinion in Rheumatology 33(5): 446-452, June 2021.
13e Peskin, M, Rubinstein, T, Jordan, N, Putterman, C, Wahezi, D: Evaluation of Mild to Moderate SLE Flare in Patient with Childhood-Onset Disease. American College of Rheumatology Annual Meeting, Washington, D.C., poster presentation November 2016.
2c